Overcoming Biopotency Barriers: Advanced Oral Delivery Strategies for Enhancing the Efficacy of Bioactive Food Ingredients

Overview

Journal Adv Sci (Weinh)

Specialty Biomedical Engineering

Date 2024 Oct 3

PMID 39361948

Authors

Ling Liu

David Julian McClements

Xuebo Liu

Fuguo Liu

Affiliations

Soon will be listed here.

Abstract

Bioactive food ingredients contribute to the promotion and maintenance of human health and wellbeing. However, these functional ingredients often exhibit low biopotency after food processing or gastrointestinal transit. Well-designed oral delivery systems can increase the ability of bioactive food ingredients to resist harsh environments inside and outside the human body, as well as allow for controlled or triggered release of bioactives to specific sites in the gastrointestinal tract or other tissues and organs. This review presents the characteristics of common bioactive food ingredients and then highlights the barriers to their biopotency. It also discusses various oral delivery strategies and carrier types that can be used to overcome these biopotency barriers, with a focus on recent advances in the field. Additionally, the advantages and disadvantages of different delivery strategies are highlighted. Finally, the current challenges facing the development of food-grade oral delivery systems are addressed, and areas where future research can lead to new advances and industrial applications of these systems are proposed.

Citing Articles

Overcoming Biopotency Barriers: Advanced Oral Delivery Strategies for Enhancing the Efficacy of Bioactive Food Ingredients.

Liu L, McClements D, Liu X, Liu F Adv Sci (Weinh). 2024; 11(44):e2401172.

PMID: 39361948 PMC: 11600209. DOI: 10.1002/advs.202401172.

References

Doan T, Forward T, Tamburini B . Trafficking and retention of protein antigens across systems and immune cell types. Cell Mol Life Sci. 2022; 79(5):275. PMC: 9063628. DOI: 10.1007/s00018-022-04303-4. View

Pace C, Grimsley G, Scholtz J . Protein ionizable groups: pK values and their contribution to protein stability and solubility. J Biol Chem. 2009; 284(20):13285-9. PMC: 2679426. DOI: 10.1074/jbc.R800080200. View

Cai Z, Lei X, Lin Z, Zhao J, Wu F, Yang Z . Preparation and evaluation of sustained-release solid dispersions co-loading gastrodin with borneol as an oral brain-targeting enhancer. Acta Pharm Sin B. 2015; 4(1):86-93. PMC: 4590720. DOI: 10.1016/j.apsb.2013.12.012. View

Dai Y, Xu C, Sun X, Chen X . Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment. Chem Soc Rev. 2017; 46(12):3830-3852. PMC: 5521825. DOI: 10.1039/c6cs00592f. View

Huang G, Huang H . Application of hyaluronic acid as carriers in drug delivery. Drug Deliv. 2018; 25(1):766-772. PMC: 6058522. DOI: 10.1080/10717544.2018.1450910. View

Guo Y, Qiao D, Zhao S, Zhang B, Xie F . Starch-based materials encapsulating food ingredients: Recent advances in fabrication methods and applications. Carbohydr Polym. 2021; 270:118358. DOI: 10.1016/j.carbpol.2021.118358. View

Chen H, Tan X, Han X, Ma L, Dai H, Fu Y . Ferritin nanocage based delivery vehicles: From single-, co- to compartmentalized- encapsulation of bioactive or nutraceutical compounds. Biotechnol Adv. 2022; 61:108037. DOI: 10.1016/j.biotechadv.2022.108037. View

Filipczak N, Pan J, Yalamarty S, Torchilin V . Recent advancements in liposome technology. Adv Drug Deliv Rev. 2020; 156:4-22. DOI: 10.1016/j.addr.2020.06.022. View

Miao Y, Chen K, Chen C, Mi F, Lin Y, Chang Y . A Noninvasive Gut-to-Brain Oral Drug Delivery System for Treating Brain Tumors. Adv Mater. 2021; 33(34):e2100701. DOI: 10.1002/adma.202100701. View

10.

Ren J, Liu Y, Yao Y, Feng L, Zhao X, Li Z . Intranasal delivery of MSC-derived exosomes attenuates allergic asthma via expanding IL-10 producing lung interstitial macrophages in mice. Int Immunopharmacol. 2020; 91:107288. DOI: 10.1016/j.intimp.2020.107288. View

11.

Liu T, Zhao Y, Wu N, Chen S, Xu M, Du H . Egg white protein-based delivery system for bioactive substances: a review. Crit Rev Food Sci Nutr. 2022; 64(3):617-637. DOI: 10.1080/10408398.2022.2107612. View

12.

Leonard W, Zhang P, Ying D, Adhikari B, Fang Z . Fermentation transforms the phenolic profiles and bioactivities of plant-based foods. Biotechnol Adv. 2021; 49:107763. DOI: 10.1016/j.biotechadv.2021.107763. View

13.

Zhang Y, Li M, Du G, Chen X, Sun X . Advancedoral vaccine delivery strategies for improving the immunity. Adv Drug Deliv Rev. 2021; 177:113928. DOI: 10.1016/j.addr.2021.113928. View

14.

Menzel C, Bernkop-Schnurch A . Enzyme decorated drug carriers: Targeted swords to cleave and overcome the mucus barrier. Adv Drug Deliv Rev. 2017; 124:164-174. DOI: 10.1016/j.addr.2017.10.004. View

15.

Bao C, Liu B, Li B, Chai J, Zhang L, Jiao L . Enhanced Transport of Shape and Rigidity-Tuned α-Lactalbumin Nanotubes across Intestinal Mucus and Cellular Barriers. Nano Lett. 2020; 20(2):1352-1361. DOI: 10.1021/acs.nanolett.9b04841. View

16.

Casanova F, Nascimento L, Silva N, De Carvalho A, Gaucheron F . Interactions between caseins and food-derived bioactive molecules: A review. Food Chem. 2021; 359:129820. DOI: 10.1016/j.foodchem.2021.129820. View

17.

Jiao Z, Wang X, Yin Y, Xia J, Mei Y . Preparation and evaluation of a chitosan-coated antioxidant liposome containing vitamin C and folic acid. J Microencapsul. 2018; 35(3):272-280. DOI: 10.1080/02652048.2018.1467509. View

18.

Xie Y, Hu F, Xiang D, Lu H, Li W, Zhao A . The metabolic effect of gut microbiota on drugs. Drug Metab Rev. 2020; 52(1):139-156. DOI: 10.1080/03602532.2020.1718691. View

19.

Sanchez Armengol E, Laffleur F . The progress on sulfhydryl modified polymers with regard to synthesis, characterization and mucoadhesion. Int J Pharm. 2020; 592:120016. DOI: 10.1016/j.ijpharm.2020.120016. View

20.

Xie D, Zhou X, Xiao B, Duan L, Zhu Z . Mucus-Penetrating Silk Fibroin-Based Nanotherapeutics for Efficient Treatment of Ulcerative Colitis. Biomolecules. 2022; 12(9). PMC: 9496219. DOI: 10.3390/biom12091263. View